15 frequently asked questions about the 2012-2013 ritonavir March-In petition

See also: /2012ritonavir

15 frequently asked questions about the 2012 ritonavir March-In petition

Q1. What is the Bayh-Dole Act?

The Bayh-Dole Act (or University and Small Business Patent Procedures Act) was originally enacted in 1980 as Public Law 96-517, and was amended in 1984 by Public Law 98-620. Among other things, the Bayh-Dole Act was designed to facilitate the patenting of U.S. government funded inventions by universities, other non-profit entities and businesses, and also:

Continue Reading

US signs Marrakesh treaty for the blind

USPTO has confirmed that on October 2, 2013, the United States has signed the Marrakesh Treaty to Facilitate Access to Published Works for Persons Who Are Blind, Visually Impaired, or Otherwise Print Disabled. The U.S. signing, which was not accompanied by a press release, took place on the last day of the WIPO General Assembly, and one day after the United States government began to shut down non-essential operations as a consequence of disputes over the Affordable Care Act.

Continue Reading

Uncategorized

Congress asked to hold hearings on NIH failure to address abuses of government financed medical inventions

We sent this letter to the Hill today.

October 8, 2013

Dear Senators Reid and McConnell, Representatives Boehner and Pelosi,

We are writing to ask that Congress hold a hearing on the failure of the NIH to exercise its authority to protect the public from abuses in federally funded inventions.

Since the passage of the Bayh­Dole Act in 1980, the Department of Health and Human Services (DHHS) has never granted a petition to “march in” to permit third parties to use patents invented on federally funded research in response to abuses of the patent rights.

Continue Reading

Uncategorized